Health research network TriNetX rakes in $40 mln Series D
Cambridge, Massachusetts-based TriNetX, a global health research network, has secured $40 million in Series D financing. Merck Global Health Innovation Fund led the round with participation from Mitsui & Co., Ltd., ITOCHU Technology Ventures, ITOCHU Corporation, MPM Capital, F2 Ventures and Deerfield Management.
13 March 2019•1 min read
